The Hepatic and Intestinal Metabolic Activities of P450 in Rats with Surgery- and Drug-Induced Renal Dysfunction

Author： Okabe H.   Hasunuma M.   Hashimoto Y.  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.20, Iss.10, 2003-10, pp. : 1591-1594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

Hepatic Metabolic Clearance of Midazolam, a Cytochrome P450 3A Substrate, in the Presence of Ketoconazole in Rats

By Higashikawa F.   Murakami T.   Makino M.   Takano M.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 8, 1999-08 ,pp. : 529-536

Pharmaceutical Press

Access to resources Recommend Favorite

Pharmacokinetic Changes of Drugs in Rat Model of Acute Renal Failure Induced by Uranyl Nitrate: Correlation Between Drug Metabolism and Hepatic Microsomal Cytochrome P450 Isozymes

By  

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 193-205

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats

By Jennings Brett   Montanez David   May Michael   Estes Anne   Fang Xiao   Yaghini Fariborz   Kanu Alie   Malik Kafait  

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 145-161

Springer Publishing Company

Access to resources Recommend Favorite

Drug-Induced Endocrine and Metabolic Disorders

By Chaker Ben Salem  

Drug Safety, Vol. 30, Iss. 8, 2007-01 ,pp. : 727-728

Adis International

Access to resources Recommend Favorite